Skip to main content

CorMedix Inc.

For the period ended Mar 31, 2026. Filed May 14, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed May 14, 2026

CRMD$5.47+2.8%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Table of Contents

INDEX

Page
PART I FINANCIAL INFORMATION1
Item 1.Unaudited Condensed Consolidated Financial Statements1
Condensed Consolidated Balance Sheets as of March 31, 2026 and December 31, 20252
Condensed Consolidated Statements of Operations and Comprehensive Income for the Three Months Ended March 31, 2026 and 20253
Condensed Consolidated Statements of Changes in Stockholders’ Equity for the Three Months Ended March 31, 2026 and 20254
Condensed Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2026 and 20255
Notes to Unaudited Condensed Consolidated Financial Statements6
Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations23
Item 3.Quantitative and Qualitative Disclosure About Market Risk29
Item 4.Controls and Procedures29
PART II OTHER INFORMATION31
Item 1.Legal Proceedings31
Item 1A.Risk Factors31
Item 2.Unregistered Sales of Equity Securities and Use of Proceeds31
Item 3.Defaults Upon Senior Securities31
Item 4.Mine Safety Disclosure32
Item 5.Other Information32
Item 6.Exhibits33
SIGNATURES34

i

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.